Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Cancers
STATEMENT OF NEED
Esophagogastric cancers include tumors of the esophagus, esophageal junction, and stomach. Esophageal cancers are the twentieth most commonly diagnosed cancer in the United States, but the eleventh leading cause of cancer death, with an estimated 21,560 cases diagnosed annually and 16,120 deaths estimated in 2023 (NCCN, 2023; Siegel et al, 2023). Given the poor prognosis of esophagogastric cancers and the complexity of personalized care planning, interdisciplinary teamwork... |
|
Fabry Disease Research Highlights
This 30-minute CME-accredited program highlights the latest clinical research about Fabry disease, a rare X-linked lysosomal disorder that results in the cellular buildup of globotriaosylceramide. Characteristic features of Fabry disease include acroparesthesias, angiokeratomas, hypohidrosis, corneal opacity, gastrointestinal problems, tinnitus, and hearing loss. Fabry disease also involves potentially life-threatening complications such as progressive kidney damage, heart attack, and stroke.
... |
|
Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
Multiple myeloma is a disease that remains incurable for most patients, many of whom become refractory to the majority of available treatments (Kumar et al, 2022). It is estimated that 35,730 new cases of multiple myeloma are diagnosed in the United States annually, and 12,590 people die of the disease (Siegel et al, 2023). Agents targeting B-cell maturation antigen (BCMA), including antibody-drug conjugates (ADCs), chimeric antigen receptor (CAR) T-cell therapies, and bis... |
|
Warm Autoimmune Hemolytic Anemia (wAIHA)
Warm autoimmune hemolytic anemia (wAIHA) is the most common type (60-70%) of autoimmune hemolytic anemia (AIHA). In most cases, wAIHA is due an immunoglobulin G (IgG) autoantibody that binds to red blood cells (RBC), leading to hemolysis.
Current recommendations for managing people with wAIHA are largely based on case series and retrospective studies involving off-label medications. Also, while there are currently no medications specifically approved to treat wAIHA, data are emerging on new... |
|
Hitting the Target in HER2-Positive Metastatic Colorectal Cancer
STATEMENT OF NEED
An estimated 153,020 new cases of colorectal cancer (CRC) are diagnosed annually, and 52,550 people die of the disease (Siegel et al, 2023). Approximately 22% of patients present with metastatic disease, which is associated with a dismal 5-year survival rate of 15% (SEER, 2022). Targeting biomarkers is a key strategy for expanding therapeutic options and improving outcomes in metastatic CRC. Human epidermal growth factor receptor 2 (HER2) amplification status and treatment... |
|
Building and Maintaining a Multidisciplinary Team for Lysosomal Disorders
This CME/CE activity with Drs. Ozlem Goker-Aplan and Walla Al-Hertani describes the importance of a multidisciplinary team approach to managing lysosomal diseases, as well as some of the challenges involved in creating and maintaining that team.
At the end of this activity, participants should be able to:
- Describe the need for a team approach to care
- Describe best practices to build a multidisciplinary team for a new patient
- Describe best practices to maintain a multidisciplinary... |
|
Expert Guidance on Current Standards and New Directions in Newly Diagnosed Multiple Myeloma
STATEMENT OF NEED
An estimated 35,730 new cases of multiple myeloma are diagnosed in the United States annually, and 12,590 people die of the disease (Siegel et al, 2023). Characterized by clonal proliferation of malignant plasma cells in the bone marrow, multiple myeloma is associated with anemia, renal insufficiency, bone destruction, and hypercalcemia, all of which significantly impact patients’ quality of life. The development of novel therapies and combinations in recent years, inclu... |
|
Myasthenia Gravis Research Highlights: AAN 2023
This 30-minute CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subtype of each patient as well as each patient’s comorbidities. There are currently four drugs approved by the FDA, eculizumab, efgartigimod, ravulizumab, and rozanolixizumab. There are also treatments in development. Clinical tria... |
|
Leveraging the Growing Arsenal of Adjuvant Therapies for Early-Stage NSCLC
In this activity, Dr. Helena A. Yu, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, will provide insights into strategies for leveraging the growing arsenal of adjuvant therapies for early-stage non"small cell lung cancer (NSCLC), including treatment selection and adverse event management. Start the activity now!
STATEMENT OF NEED
Lung cancer is the second most commonly diagnosed cancer and the leading cause of death for men and women worldwide. In the Unite... |
|
Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer: Case Explorations and Answers to FAQs
STATEMENT OF NEED
Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for approximately 10% to 15% of breast cancer diagnoses and is characterized by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). TNBC is more common in Black women and in women under the age of 40 (ACS, 2023). Compared with other subtypes of invasive breast cancer, TNBC has high rates of metastasis and a poor prognosis. Due to the lack ... |
|
Virtual Tumor Board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma
STATEMENT OF NEED
Sarcomas, which represent 1% to 2% of adult cancers, are a rare, heterogeneous group of neoplasms originating in the connective tissue. Soft tissue sarcomas, which begin in the muscle, tendons, fat, lymph, blood vessels, and nerves, encompass more than 80 histological subtypes. Approximately 25% of patients develop metastatic disease after curative-intent surgery, and for these patients, treatment options are limited and prognosis is very poor. In recent decades, the ident... |
|
Putting the Freeze on Cold Agglutinin Disease
STATEMENT OF NEED
Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia (AIHA) in which antibodies cause hemolysis at cold temperatures, generally between 37º to 39º Fahrenheit. Approximately 1 in a million people are affected by CAD annually, with onset usually occurring between the ages of 40 and 80 years. Individuals commonly experience fatigue, dizziness, palpitations, and shortness of breath caused by the anemia; jaundice caused by degradation of hemoglobin i... |
|
|
Managing Patients with Rheumatic Disorders in Primary Care
Rheumatic disorders are prevalent, yet their diagnosis and treatment in affected patients are frequently challenging, contributing to a considerable disease burden. Ensuring timely intervention is critical to slow disease progression and improve patient outcomes. However, various educational gaps impede primary care clinicians from effectively achieving these goals. This 0.75-hour text-based activity features 3 modules comprised of 12 questions encountered in the primary care management of pat... |
Infection Control OSHA Focus | Accredited all 50 states | #1 Bestseller for Dental License Renewal | Dentists, Hygienists, Assistants
Online CE | Dental Infection Control OSHA Focus MyDentalCE.com | All 50 states 2023-2024. Meets state dental board requirements in all 50 states for 2 credit hours of instruction for license renewal in infection control and bloodborne pathogen review. Includes current information from OSHA, CDC, and various board updates. Reviews bloodborne pathogens, PPE, sterilization technique, chain of infection control, current topics like immunization and waste disposal, lists resources for the office, ... |
|
Managing Cardiomyopathies in Lysosomal Disorders
This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with cardiomyopathies.
At the end of this activity, participants should be able to:
- Describe the role of the cardiologist in the team approach to care
- Describe best practices to monitor cardiac symptoms in lysosomal disorders
- Describe best practices to treat cardiac symptoms in lysosomal disorders |
|
Acromegaly Research Highlights: ENDO 2023
This 30-minute CME-accredited program highlights the latest clinical research about acromegaly, a rare endocrine disorder. Common symptoms include subtle skeletal overgrowth; soft tissue swelling (tongue, heart, kidney, colon, and vocal cords); unusually prominent forehead and heavy brow ridge; protruding lower jaw; overbite; skin thickening; increased shoe and ring size; hypertension; increased perspiration; headaches; paresthesia; and sexual dysfunction.
There are several orphan drugs app... |
|
Managing Immune Related Adverse Events to Ensure Optimal Cancer Immunotherapy Outcomes: The Nurse’s View
STATEMENT OF NEED
Immune checkpoint inhibitors, which alter immune regulatory pathways and promote cell-mediated destruction of tumor cells, have revolutionized the treatment of cancer in recent years, with numerous therapeutic agents approved and several targets under investigation (Chennamadhavuni et al, 2022). However, up to 90% of patients receiving immune checkpoint inhibitors experience immune-related adverse events, which can affect a wide variety of organ systems and can occur at any ... |
|
Cushing’s Disease Research Highlights: ENDO 2023
This 30-minute CME program highlights the latest clinical research about Cushing’s disease.
Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor that leads to excessive levels of cortisol.
This CME program, hosted by Lisa Machtigall, MD, Clinical Director, Neuroendocrine & Pituitary Tumor Clinical Center at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School, provides an overview of the latest cli... |
|
New Guidance to Diagnose and Treat Tumor-induced Osteomalacia (TIO)
This 30-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster University, highlights the best practices to diagnose and treat tumor induced osteomalacia (TIO) based on the recently published global guidance document in the Journal of Internal Medicine.
This activity has been designed to meet the educational needs of physicians specializing in neurology, orthopedics, internal medicine/general practice, rheumatology, endocrinology, pain management... |
|
Myasthenia Gravis and the Complement System
This 45-minute CME-accredited program, hosted by James F Howard Jr, MD, Professor of Neurology, Medicine & Allied Health at The University of North Carolina at Chapel Hill, highlights the connection between the complement system and myasthenia gravis in regards to the pathophysiology and treatment of this rare disease.
After participating in the activity, learners should be better able to:
- Review the pathophysiology of MG.
- Describe the role of the complement system in MG.
- Descr... |
|
Assessing, Monitoring, and Managing Respiratory Involvement in Lysosomal Disorders
Ozlem Gore-Alpan, MD of LDRTC and John Bach, MD, Professor of Neurology at Rutgers School of Medicine discuss best practices to manage respiratory complications in persons with lysosomal disorders.
At the end of this activity, participants should be able to:
- Describe the most common LSDs that have pulmonary complications.
- Describe best practices to manage pulmonary symptoms in Pompe disease.
- Describe best practices to manage pulmonary symptoms in MPSs.
- Describe best practices to... |
|
MyDentalCE.com | Online Dental CE for Dentists, Hygienists, Assistants | #1 Rated in Prompt Customer Service | Instant Certificate upon Course Completion
Affordable Online CE courses for Dentists, Hygienists, and Assistants | Instant Completion Certificate | OSHA and regulatory training in Infection Control ,Bloodborne Pathogens, Hazard Communication, HIPAA, Radiography Review and many new and current courses. Packages and group discounts available. #1 in Customer Service for Online Self Study | CEsupport@mydentalce.com Customer service hotline: (530) 238-5333. Questions welcome! |
|
Ohio Dental Radiography Review for Dental Assistants 2023-24 | 2 CEs Updated | Certificate Renewal & all 50 states | AGD PACE recognized provider | Affordable & Fast
Ohio Radiography Review for Dental Assistants (Ohio for certificate renewal). Take MyDentalCE.com online review course and get an instant certificate upon completion. This updated for 2023-24 Radiography Review for dental assistants is designed for the license renewal board requirements in Ohio as well as any other state in the US. The course is a straightforward review of dental assistant radiography principles. Academy of General Dentistry PACE #373218 recognized provider in all 50 states in... |
|
California Dental CE Online | $99 for 25 CEs | MyDentalCE.com | Board Approved Infection Control & Dental Practice Act & Opioid Required course | 2022-24
25 CEs | $99. For California dentists including Cal OSHA Infection Control, California Dental Practice Act (both mandatory & board approved for 2023-2024), board newly approved Opioid Responsibilities, and Bloodborne Pathogens Standard Review. We also can do course substitutions & we offer group discounts. Immediately upon purchase, we send you links to the PDF course files with instructions and all the course download links. The examination links easily accessible in each course. Un... |
|
OSHA Annual Review Training for Dental Staff with Interactive Videos - "New Hire" Training | Includes IC, BBP, HazCom, HIPAA Intro
New Dental OSHA Annual & New Hire Training with HIPAA introduction + Respectful Workplace. The format is a blend of text and videos located throughout the course. All updated topics including COVID's impact. Covers Infection Control, Bloodborne Pathogens, HazCom, HIPAA intro and provides resources, apps, and checklists.
You can choose form a "single" course and 3-5-10 packages. More than 20, contact our office for deep discounted quote. Instant completion certificate. The s... |
|
California Opioid Prescribers: Responsibilities and Requirements | Board Approved Mandated Course
On January 1, 2023, the Dental Board of California (DBC) and CA Law mandated that all Schedule II Opioid prescribers, including dentists, take a dental board approved course to fulfill the CE mandate. This brand new text-based PDF file self-instruction course is based on explicit content guidelines issued by the DBC and the Calif Code of Regulations. This 2023-2024 DBC approved course covers best practices in pain management, resources for Substance Abuse Disorder, and the regulations, respons... |
|
Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults
STATEMENT OF NEED
Acid sphingomyelinase deficiency (ASMD) is a rare, hereditary lysosomal storage disease with multisystemic manifestations, including splenomegaly, hepatomegaly, interstitial lung disease, dyslipidemia, bone marrow and lymph node involvement, and sometimes neurological and peripheral nerve involvement. While the most severe form of ASMD, infantile neurovisceral ASMD, results in death in early childhood, chronic forms of ASMD have more prolonged survival but are associated w... |
|
Current Standards and New Directions in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
STATEMENT OF NEED
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life-threatening thrombotic microangiopathy with a rapid onset and progression and a mortality rate of 10% to 20% with prompt treatment. Onset of aTTP is characterized by severe thrombocytopenia, microangiopathic hemolytic anemia, and a constellation of associated symptoms including hemorrhage, neurologic and renal manifestations, cardiac abnormalities, and mesenteric ischemia (Joly et al, 2017). Survivors of f... |
|
Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes
STATEMENT OF NEED
Head and neck cancers represent a heterogeneous group of tumors that originate in the lip/oral cavity, hypopharynx, oropharynx, nasopharynx, and larynx. An estimated 66,470 new cases are diagnosed in the United States annually, and 15,050 people die of the disease (Siegel et al, 2022). Approximately 90% of cases are classified as head and neck squamous cell carcinoma (HNSCC). Treatment of HNSCC is complicated by numerous factors, including differing therapeutic strategies ... |
|
Exploring Novel Treatments for Rett Syndrome
STATEMENT OF NEED
Rett syndrome is a rare, debilitating neurodevelopmental disorder almost always associated with a spontaneous mutation in the methyl-CpG-binding protein 2 (MECP2) gene on the X-chromosome. Affected individuals experience loss of purposeful hand skills, abnormalities in gait, loss of spoken language, and stereotypic hand movements, with more severe manifestations including seizures, autistic features, autonomic nervous system dysfunction, breathing abnormalities, sleep dist... |
|
Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy
STATEMENT OF NEED
Chemotherapy-induced peripheral neuropathy (CIPN) is a complication of cancer treatment that may impair quality of life and lead to dose reductions or discontinuation of treatment. In one study, among 105 patients receiving paclitaxel for breast cancer, 36.2% needed dose reductions due to CIPN (Timmins et al, 2021). Whereas in some patients the symptoms improve with time, in others, there is progression with permanent nerve damage (Zajączkowska et al, 2019). At present, the... |
|
Sexual Harassment Prevention
Sexual Harassment (required CE by the State of Illinois) |
|
Navigating pain management, safe opioid prescribing, and opioid use disorder
This program is presented in six thirty minute sessions that can be completed individually.
The sessions are:
Session 1: Pain Taxonomy, pathogenesis, and assessment
Session 2: Developing a patient-centered pain treatment plan
Session 3: Non-opioid analgesics: Evidence and clinical pearls
Session 4: Opioid analgesics: From A to Z
Session 5: Clinical use of opioids: Safe prescribing and appropriate monitoring
Session 6: The exit strategy: When the treatment becomes the ... |
|
|
Tools & Techniques to Enhance Surgical Efficacy & Efficiency
This series of six webcasts offers insight on various issues that are important to eye care professionals. Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and the... |
|
Tools & Techniques to Enhance Surgical Efficacy & Efficiency
This series of six webcasts offers insight on various issues that are important to eye care professionals. Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and the... |
|
PAH Clinical Scenarios: Advances in Diagnostic Assessment, Guideline-Recommended Care, and Emerging Treatments
Target Audience
This educational activity is designed for pulmonologists and cardiologists, primarily, as well as physicians in internal medicine, primary care, and family medicine, physician assistants, nurse practitioners, and other healthcare providers who may be involved in managing care for patients with pulmonary arterial hypertension (PAH).
Program Overview
PAH is a rare, life-threatening disorder characterized by elevated pressure in the pulmonary arteries that quickly progresses ... |
|
Expert Illustrations & Commentaries™: A Closer Look at Emerging Therapies in IBS-C
Target Audience
This educational activity is directed towards gastroenterologists, nurse practitioners, physician assistants, and other health care practitioners involved in the management of patients with IBS.
Activity Overview
The availability of new therapeutic strategies, as well as growing clinical experience with current therapies for irritable bowel syndrome with constipation (IBS-C), creates a need for ongoing education. This online, on-demand virtual symposium brings together ren... |
|
Neuromyelitis Optica Spectrum Disorder: Optimizing Clinical Decision-Making in a Rapidly Evolving Therapeutic Landscape
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system that mainly manifests through recurrent attacks of optic neuritis and longitudinally extensive transverse myelitis. Although early detection is critical for improved outcomes, misdiagnosis is common during the early stages of disease. The application of newer diagnostic criteria and methods may facilitate a differential diagnosis. Until recently, treatment options have been limited, but th... |
|
MedEd Talks: Case-Based Conversations in Rheumatology
Immune-mediated inflammatory disease (IMID) is a group of clinically heterogeneous autoimmune disorders that includes psoriatic arthritis, systemic lupus erythematosus, vasculitis, and many others. Recognizing the underlying immunopathologic mechanisms of these disorders is essential for understanding how new and emerging biologic and small molecule therapies exert their effects, enabling optimal incorporation of these agents into current treatment paradigms. In this CME podcast series, expert... |
|
Chronic Versus Acute: Rethinking Dry Eye Disease
This continuing education activity (CE) captures content from a virtual roundtable discussion.
ACTIVITY DESCRIPTION
Dry eye disease (DED) is a significant public health issue that threatens patient economic productivity and quality of life. About 16 million Americans have a formal DED diagnosis, but the true incidence is likely much higher because many who are symptomatic may not seek medical care. This supplement addresses this issue and others related to managing DED and providing the ... |
|
Community Practice Connections: Optimizing Recognition and Management of Acute Hepatic Porphyria
Target Audience
This educational activity is directed toward hepatologists and gastroenterologists. Nurses, specialty nurse practitioners, physician assistants, and other clinicians involved in the management of patients with liver diseases are invited to attend.
Program Overview
Acute hepatic porphyria (AHP) is a rare genetic disease caused by enzymatic defects that result in the accumulation of toxic intermediates in the liver. Because AHP symptoms are nonspecific, they are often misdia... |
|
Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis
Target Audience
This educational activity is directed toward cystic fibrosis specialists specialists, pulmonologists, pediatricians, gastroenterologists, nurse practitioners, physician assistants, nurses, and other clinicians who provide care for patients with CF.
Program Overview
Addressing Healthcare Inequities is a video-based program in which 3 experts discuss health disparities that negatively impact patients with CF. Access to care, insurance costs, and unintended bias are just some... |
|
Expert Illustrations & Commentaries™: Emerging Strategies for the Treatment of Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients
Target Audience
This educational activity is directed toward transplant physicians, transplant surgeons, and nephrologists. Other clinicians who manage renal transplant patients are invited to participate.
Activity Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiology and management of antibody-mediated renal transplant rejection. In this activity the faculty focus on the pathophysiology, current and emerging therapeutic st... |
|
Gene Therapy for Hemophilia: What Does the Future Hold?
Target Audience
This educational activity is directed toward hematologist/oncologists, pediatricians, emergency medicine clinicians, geneticists, genetic counselors, nurse practitioners, physician assistants, registered nurses, and other health care professionals involved in the management of hemophilia.
Program Overview
Despite recent improvements in options for its treatment, hemophilia continues to have a significant negative impact on patients’ functionality and health-related quali... |
|
Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED
Target Audience
This educational activity is directed towards ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with dry eye disease and meibomian gland dysfunction.
Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which two experts discuss the management of meibomian gland dysfunction (MGD)-associated dry eye disease (DED). In this activity, the faculty focus on the etiology of MGD-associate... |
|
Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED
Target Audience
This educational activity is directed towards ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with dry eye disease and meibomian gland dysfunction.
Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which two experts discuss the management of meibomian gland dysfunction (MGD)-associated dry eye disease (DED). In this activity, the faculty focus on the etiology of MGD-associate... |
|
Community Practice Connections™: Exploring the Potential Role for Gene Therapy in Hemophilia B
Target Audience
This activity is directed toward hematologists and hematologist-oncologists. Pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with hemophilia B are invited to participate.
Activity Overview
In hemophilia B, an absence of clotting factor IX leads to a failure to facilitate and stabilize the primary platelet and fibrin plug that initially forms a clot. As a result, patients experience prolonged blee... |
|
Using Continuous Glucose Monitoring and the Ambulatory Glucose Profile in Clinical Decision-Making for Primary Care
Target Audience
This activity is designed to meet the educational needs of primary care practitioners treating patients with diabetes.
Program Overview
This activity will cover the importance of continuous glucose monitoring in the treatment of diabetes, the available personal and professional FDA-approved CGM devices, how to access and interpret the ambulatory glucose profile (including case studies) and information about incorporating CGM into the practice workflow and billing for CGM.
... |
|
New Conversations About Long-Acting Reversible Contraceptives: Patient Stories and Expert Reflections
Despite having the highest rates of effectiveness amongst contraceptives, few women in the U.S. use long-acting reversible contraceptives (LARCs), placing them at risk of unintended pregnancies. Myriad of clinician, systemic, and patient factors contribute to low rates of use. Education on the appropriate use of LARCs along with proper insertion techniques has been demonstrated to increase their use and reduce unintended pregnancy rates. Expanding the number of providers with background in LAR... |
|
The Basics of Exercise Physiology: Improving Wellness through the Benefits of Exercise
The Basics of Exercise Physiology online nursing course will help healthcare professionals understand the body's responses to exercise. Participants completing this course will be able to educate patients in the appropriate physical activity to ease chronic conditions or meet their personal goals. |